Your browser doesn't support javascript.
loading
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform
Serruys, Patrick W; Sianos, Georgios; Abizaid, Alexandre; Aoki, Jiro; den Heijer, Peter; Bonnier, Hans; Smits, Pieter; McClean, Dougal; Verheye, Stefan; Belardi, Jorge; Condado, Jose; Pieper, Michel; Gambone, Louise; Bressers, Marco; Symons, Janette; Sousa, Eduardo; Litvack, Frank.
  • Serruys, Patrick W; Erasmus Medical Center. NL
  • Sianos, Georgios; Erasmus Medical Center. NL
  • Abizaid, Alexandre; Instituto Dante Pazzaneses de Cardiologia. BR
  • Aoki, Jiro; Erasmus Medical Center. NL
  • den Heijer, Peter; Amphia Ziekenhuis. NL
  • Bonnier, Hans; Catharina Ziekanhuis. NL
  • Smits, Pieter; Medish Centrum Rijnmond-Zuid. NL
  • McClean, Dougal; Christchurch Hospital. NL
  • Verheye, Stefan; Academish Zienkenhuis. NL
  • Belardi, Jorge; Instituto Cardiovascular de Buenos Ayres. AR
  • Condado, Jose; Hospital Miguel Perez Carrenas. VE
  • Pieper, Michel; Herzzentrum Bodensee. CH
  • Gambone, Louise; Conor Medsystem. US
  • Bressers, Marco; Cardialysis. NL
  • Symons, Janette; Cardialysis. NL
  • Sousa, Eduardo; Instituto Dante Pazzaneses de Cardiologia. BR
  • Litvack, Frank; Conor Medsystem. US
J. Am. Coll. Cardiol ; J. Am. Coll. Cardiol;46(2): 253-260, 2005. ilus, tab
Article en En | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1063731
Biblioteca responsable: BR79.1
Ubicación: BR79.1
ABSTRACT
The aim of this study was to evaluate th effect of variable dose and release kinetics of paclitaxel on neointimal hyperplasia.Conventional paclitaxel-eluting stents use a durable polymer coating as vehicle for drug delivery.The Conor stent (Conor Medsystem, Menlo Park, Califórnia) with intra-strut wells and erodable polymer is specifically designed for drug delivery with programmable pharmakocinetics.Two hundred and forty-four patients with single vessel disease received either a bare metal Conor stent(n=53) or one of six different release formulations that varied in dose (10 or 30yg) and elution release kinetics (first order, zero oder), direction (abluminal, luminal), and duration (5, 10, and 30 days)...
Asunto(s)
Search on Google
Colección SES: Producao_cientifica Banco de datos: SES-SP / SESSP-IDPCPROD Asunto principal: Stents / Paclitaxel / Hiperplasia Idioma: En Año: 2005 Tipo del documento: Article
Search on Google
Colección SES: Producao_cientifica Banco de datos: SES-SP / SESSP-IDPCPROD Asunto principal: Stents / Paclitaxel / Hiperplasia Idioma: En Año: 2005 Tipo del documento: Article